drugset / Trial / NCT00698490

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

NCT00698490

Phase 1/2 Completed 130 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to compare, in healthy HSV seronegative and HSV seropositive subjects, the humoral and cellular immune response of herpes simplex candidate vaccines containing gD from two different cell lines and using gD-Alum as control.

Timeline

Start
1995-08
Primary completion
1997-01
Completion
1997-01

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK208141 Vaccine Intramuscular
Subject gD-Alum Unknown Intramuscular

Indications

No indication recorded.